COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq: SPNC) today announced it has completed the closing of the transaction to acquire the endovascular business of Kensey Nash and has begun commercialization of the acquired products.
